Experiences with
Onglyza6 public posts
FDA Warns of Heart Failure Risk With Two Diabetes Drugs
The US Food and Drug Administration (FDA) has issued a new alert about the potential for increased risk for heart failure in patients taking the type 2 diabetes drugs saxagliptin (Onglyza, AstraZeneca Pharmaceuticals LP) and alogliptin (Nesina, Takeda Pharmaceuticals).
Want to take advantage of all our features? Just log in!
or